Intellipharmaceutics International Inc. (IPCI)

[tilator]

I think the thing that changed my tune was the poor performance of seroquol xr.

Same here. Someone told before, MNK missed timeframe with som long lasting deals, but they will be open again. Hopefully MNK will do better then. At least there is much more room upwards than down.

If MNK have now something like 4-5% market share, it is not too much asked they have to least double that in a few months.

If Focalin sales goes a bit upwards too, this might look better next year.